Tim Brighton
Overview
Explore the profile of Tim Brighton including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
124
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tran H, Dix C, Bird R, Chunilal S, Brighton T, Reynolds J, et al.
Am J Hematol
. 2024 Dec;
100(3):516-519.
PMID: 39715073
No abstract available.
2.
Merriman E, Chunilal S, Brighton T, Chen V, McRae S, Ockelford P, et al.
Thromb Res
. 2021 Sep;
207:33-39.
PMID: 34530387
Background: Treatment of low-risk patients with isolated symptomatic distal deep vein thrombi (IDDVT) is uncertain. Objective: assess whether two weeks of therapeutic anticoagulation is efficacious/safe for IDDVT. Primary Outcome: symptomatic...
3.
Hocking J, Chunilal S, Chen V, Brighton T, Nguyen J, Tan J, et al.
Med J Aust
. 2021 Jun;
215(1):19-20.e1.
PMID: 34117641
No abstract available.
4.
Tran H, Brighton T, Grigg A, McRae S, Dixon J, Thurley D, et al.
Br J Haematol
. 2014 Jul;
167(2):243-51.
PMID: 25041261
The efficacy of a fixed-dose rituximab schedule was prospectively explored in primary/acute refractory, relapsed or chronic (platelet count >10 × 10(9) /l and ≤50 × 10(9) /l) idiopathic thrombocytopenic purpura...
5.
Nourse J, Lea R, Crooks P, Wright G, Tran H, Catalano J, et al.
Blood Coagul Fibrinolysis
. 2011 Oct;
23(1):45-50.
PMID: 22024796
Adult immune thrombocytopenia (ITP) is a heterogeneous disease and its immunobiology is incompletely understood. Establishing associations between candidate genes and ITP susceptibility may provide insight into pathogenesis. Previous studies have...
6.
Iland H, Bradstock K, Seymour J, Hertzberg M, Grigg A, Taylor K, et al.
Haematologica
. 2011 Oct;
97(2):227-34.
PMID: 21993673
Background: Initial therapy for patients with acute promyelocytic leukemia most often involves the combination of all-trans-retinoic acid with anthracycline-based chemotherapy. The role of non-anthracycline drugs in induction and consolidation is...
7.
McLintock C, Brighton T, Chunilal S, Dekker G, McDonnell N, McRae S, et al.
Aust N Z J Obstet Gynaecol
. 2011 Oct;
52(1):14-22.
PMID: 21972999
Venous thromboembolism (VTE) in pregnancy and the postpartum is an important cause of maternal morbidity and mortality; yet, there are few robust data from clinical trials to inform an approach...
8.
McLintock C, Brighton T, Chunilal S, Dekker G, McDonnell N, McRae S, et al.
Aust N Z J Obstet Gynaecol
. 2011 Sep;
52(1):3-13.
PMID: 21950269
Pregnancy is a risk factor for venous thromboembolism (VTE), an important cause of maternal morbidity and mortality. Although there is a 4-5-fold increased risk compared to that of nonpregnant women...
9.
Mallarkey G, Brighton T, Thomson A, Kaye K, Seale P, Gazarian M
Drugs
. 2008 Aug;
68(12):1665-89.
PMID: 18681490
We have analysed the published literature on eptacog alfa (recombinant factor VIIa; rFVIIa) for nonhaemophiliac conditions with the aim of determining its current place in therapy. Initial surgical and/or medical...
10.
Zhao L, Gaudry L, Dunkley S, Brighton T, Guo Z, Ye Z, et al.
Platelets
. 2008 Jan;
19(1):24-31.
PMID: 18231935
Platelet and leucocyte activity are important in the acute development of thrombosis and in the pathogenesis of ischaemic vascular disease. Dan Shen Di Wan (DS, Cardiotonic Pill or Dantonic(R) Pill)...